Toosendanin Alleviates Cerebral Ischemia/Reperfusion Injury via Inhibiting Neural Ferroptosis Through Lipid Metabolic Reprogramming in MCAO Mice
CNS Neuroscience & Therapeutics · 2026-06 · 32 (6)
DOI: 10.1002/cns.70952 ↗Kurz gefasst
Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 29.05.2026. Verfasst von Xinyun Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Rehabilitation, Hangzhou Medical College, Hangzhou, China. Hauptthemen laut MEDLINE: Reperfusion Injury, Ferroptosis, Infarction, Middle Cerebral Artery, Neuroprotective Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: "Pioneer and Leading Goose + X" Technology Program, Zhejiang Traditional Chinese Medicine Science and Technology Program, Zhejiang Provincial Rehabilitation Medicine Association Scientific Research Special Fund Project.
Abstract (Originalsprache)
Background
The crosstalk between ferroptosis and neuroinflammation plays an important role in the pathogenesis of cerebral ischemia–reperfusion injury. Toosendanin (TSN), a triterpenoid compound, exhibits a wide range of pharmacological activities in human diseases. Here we investigated the potential neuroprotective effects of TSN in cerebral ischemia–reperfusion injury.
Methods
In our study, in vivo murine middle cerebral artery occlusion (MCAO) model and in vitro oxygen–glucose deprivation/reoxygenation (OGD/R) model were constructed to mimic cerebral ischemia–reperfusion injury. TTC staining, open‐field test, Morris water maze test, hanging wire test, rotarod test, foot‐fault test, hematoxylin and eosin (H&E) staining, flow cytometry, western blot and reverse transcription‐quantitative PCR were conducted to evaluate the potential influence of TSN in cerebral ischemia–reperfusion injury.
Results
Our results indicated that post‐stroke administration of TSN significantly reduced infarct volume and improved long‐term functional recovery of MCAO mice. Mechanistically, TSN alleviated neural oxidative stress, lipid peroxidation, and ferroptosis in MCAO mice or in vitro after OGD/R. In addition, TSN modulated the infiltrating of immune cells in MCAO mice in vivo and T cell differentiation in vitro. Mechanistically, TSN directly interacted with ACSL4 and suppressed its enzymatic activity, thus suppressing the ACSL4/LPCAT3 axis to reduce the incorporation of pro‐ferroptotic polyunsaturated fatty acids (PUFA) into phospholipids, and finally inhibiting lipid peroxidation and neural ferroptosis. In addition, the induction of ferroptosis abrogated the influence of TSN on immune infiltration and lipid metabolism in MCAO mice.
Conclusion
Our findings identify TSN as a promising therapeutic agent for cerebral ischemia–reperfusion injury via inhibiting ACSL4‐mediated ferroptosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Rehabilitation, Hangzhou Medical College, Hangzhou, China.
- Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou, China.
- Department of Rehabilitation Medicine, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, China.
- Department of Foot and Ankle, Department of Foot and Ankle Surgery, Xiaoshan District Hospital of Traditional Chinese Medicine, Hangzhou, China.
- Department of Rehabilitation Medicine, The First People's Hospital of Xiaoshan District, Hangzhou, China.
ORCID-Profile: Jiejin Zhao
Förderung
- "Pioneer and Leading Goose + X" Technology Program
- Zhejiang Traditional Chinese Medicine Science and Technology Program
- Zhejiang Provincial Rehabilitation Medicine Association Scientific Research Special Fund Project
- Basic Scientific Research Project of Hangzhou Medical College
- Zhejiang Province Medical and Health Science and Technology Project
Zitieren
APA
Li, X., Zhao, Z., Zhao, J., Ye, X., Xiong, Z., & Zhao, J. (2026). Toosendanin Alleviates Cerebral Ischemia/Reperfusion Injury via Inhibiting Neural Ferroptosis Through Lipid Metabolic Reprogramming in MCAO Mice. CNS Neuroscience & Therapeutics, 32(6). https://doi.org/10.1002/cns.70952
Vancouver
Li X, Zhao Z, Zhao J, Ye X, Xiong Z, Zhao J. Toosendanin Alleviates Cerebral Ischemia/Reperfusion Injury via Inhibiting Neural Ferroptosis Through Lipid Metabolic Reprogramming in MCAO Mice. CNS Neuroscience & Therapeutics. 2026;32(6). doi:10.1002/cns.70952
BibTeX
@article{Li2026,
author = {Li, Xinyun and Zhao, Zhiyong and Zhao, Jingting and Ye, Xiangming and Xiong, Zhenfei and Zhao, Jiejin},
title = {Toosendanin Alleviates Cerebral Ischemia/Reperfusion Injury via Inhibiting Neural Ferroptosis Through Lipid Metabolic Reprogramming in MCAO Mice},
journal = {CNS Neuroscience & Therapeutics},
year = {2026},
volume = {32},
number = {6},
doi = {10.1002/cns.70952}
}
EUVIMED